News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Join for SIOP Nursing Network CARE Working Group Webinar
SIOP/LinkedIn
Aug 11, 2025, 16:38

Join for SIOP Nursing Network CARE Working Group Webinar

International Society of Paediatric Oncology (SIOP) shared a post on LinkedIn:

“Join us for ‘Multidisciplinary Management of Paediatric Oncology Emergencies in a Child with Burkitt Lymphoma: A Case Study’ from the SIOP Nursing CARE Working Group.

  • August 20, 2025
  • 15:00 CEST”

SIOP

More posts featuring the International Society of Paediatric Oncology on OncoDaily.

cancer International Society of Paediatric Oncology OncoDaily Oncology SIOP
Special Coverage
Societies
Aug 11, 2025, 16:38
Join for SIOP Nursing Network CARE Working Group Webinar
Insight
Aug 11, 2025, 16:37
Expanding Access to Advanced Solid Tumour Trials in Asia-Pacific: ASTER Study
Insight
Aug 11, 2025, 16:00
Jonathan Spicer: Same Day Discharge After Lung Resection - Is It Safe and Feasible?
Societies
Aug 11, 2025, 15:57
Nutrition in Paediatric Haematopoietic Stem Cells Transplantation - SIOPE
Insight
Aug 11, 2025, 15:45
Vepdegestrant Breaks New Ground in ER+ Breast Cancer - The Babak Lab
Voices
Aug 11, 2025, 15:30
How Is Reirradiation Used in Practice? - ESTRO
Insight
Aug 11, 2025, 15:18
Applonia Rose: New in Technology in Cancer Research and Treatment
Science
Aug 11, 2025, 15:15
Nieves Martinez Lago: Controversies in NEN - ENETS Statement on NET G3
Voices
Aug 11, 2025, 15:00
Guillermo de la Vega Barrancos Shares his EACR Travel Fellowship Journey
Voices
Aug 11, 2025, 14:51
Ed Kim: City of Hope to Open Orange County’s First Cancer Specialty Hospital
Voices
Aug 11, 2025, 14:29
Back-to-School for Kids Fighting Cancer - Aladina Foundation
FDA Approvals
Aug 11, 2025, 14:19
FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer